Patients taking AstraZeneca Plc’s cholesterol-lowering medicine Crestor in a study were less likely to develop pneumonia, a finding that potentially will broaden use of such drugs.
BusinessWeek.com -- Top News, Business Week
Mon, 09/13/2010 - 9:12am
Patients taking AstraZeneca Plc’s cholesterol-lowering medicine Crestor in a study were less likely to develop pneumonia, a finding that potentially will broaden use of such drugs.